This case study looks at the challenges faced by a 27-year-old woman diagnosed with adult ADHD after struggling for 13 years with dysthymia and generalized anxiety disorder. The patient showed symptoms such as inattention, restlessness, impulsivity, and emotional instability, which often blurred the lines with mood and anxiety disorder symptoms, making diagnosis tricky. Assessment tools like the Adult ADHD Self-Report Scale (ASRS), Hamilton Anxiety Scale (HAM-A), and Bender Gestalt Test (BGT) were used to clarify the diagnosis. After a structured six-month treatment plan that included medication and Mandala Art Therapy, the patient showed significant improvements in attention, emotional stability, and anxiety management. This case emphasizes the difficulties in diagnosing adult ADHD, the importance of thorough assessment, and the benefits of combined therapeutic methods. It also highlights the need for greater awareness and holistic treatment options for individuals with coexisting psychiatric issues.
1. Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., Spencer, T., Ustun, T. B., Walters, E. E., & Zaslavsky, A. M. (2006). The Prevalence and Correlates of Adult ADHD in the United States: Results From the National Comorbidity Survey Replication. American Journal of Psychiatry, 163(4), 716–723. https://doi.org/10.1176/ajp.2006.163.4.716
2. Nimmo-Smith, V., Merwood, A., Hank, D., Panagiotidi, M., Asherson, P., & Sonuga-Barke, E. (2020). Non-pharmacological interventions for adult ADHD: a systematic review. Psychological Medicine, 50(4), 529–541. https://doi.org/10.1017/S0033291720000069
3. Faraone, S. V., Biederman, J., & Mick, E. (2006). The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies. Psychological Medicine, 36(2), 159–165. https://doi.org/10.1017/S003329170500471X
4. Young, S., Asherson, P., Lloyd, T., Absoud, M., Arif, M., Colley, W., & Das, D. (2021). Failure of healthcare provision for attention-deficit/hyperactivity disorder in the UK: A consensus statement. BMJ Evidence-Based Medicine, 26(6), 161–164. https://doi.org/10.1136/bmjebm-2020-111507
